Homology Medicines, Inc. (FIXX)

NASDAQ: FIXX · IEX Real-Time Price · USD
2.94
-0.03 (-1.01%)
At close: Aug 8, 2022 4:00 PM
2.99
+0.05 (1.70%)
After-hours: Aug 8, 2022 4:55 PM EDT
-1.01%
Market Cap 168.71M
Revenue (ttm) 5.47M
Net Income (ttm) -2.59M
Shares Out 57.39M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 350,589
Open 3.05
Previous Close 2.97
Day's Range 2.65 - 3.10
52-Week Range 1.30 - 8.90
Beta -0.37
Analysts Buy
Price Target 12.38 (+321.1%)
Earnings Date Aug 10, 2022

About FIXX

Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing for various genetic disorders. The company's various set of AAVHSCs allows company to target, through a single injection, a range of disease-relevant tissues, including the liver, cen... [Read more...]

Industry Biotechnology
Founded 2015
CEO Arthur Tzianabos
Employees 224
Stock Exchange NASDAQ
Ticker Symbol FIXX
Full Company Profile

Financial Performance

In 2021, FIXX's revenue was $33.97 million, an increase of 1,157.25% compared to the previous year's $2.70 million. Losses were -$95.76 million, -25.59% less than in 2020.

Financial Statements

Analyst Forecast

According to 16 analysts, the average rating for FIXX stock is "Buy." The 12-month stock price forecast is 12.38, which is an increase of 321.09% from the latest price.

Price Target
$12.38
(321.09% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Homology Medicines Announces Peer-Reviewed Publication on Novel Discovery of AAVHSC with Robust Distribution to the C...

AAVHSC16 Biodistribution Properties in Preclinical Models Demonstrated Potential for Systemic Delivery of Genetic Medicines to Brain, Heart and Muscle

Homology Medicines to Present at Upcoming Conferences on its Gene Editing and Gene Therapy Programs for PKU

BEDFORD, Mass., June 29, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today participation and presentations at the following conferences:

FIXX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 24, 2022 in the Class Action Filed on Behal...

New York, New York--(Newsfile Corp. - May 24, 2022) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Homology Medicines, Inc. (NASDAQ: FIXX) alleg...

SHAREHOLDER ALERT FILING DEADLINE TODAY: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in H...

NEW YORK , May 24, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Homology Medicines, Inc. ("Homology" or the "Company") (NASDAQ: FIXX) and certain of it...

Homology Class Action: Levi & Korsinsky Reminds Homology Medicines, Inc. Investors of the Pending Class Action Lawsui...

New York, New York--(Newsfile Corp. - May 24, 2022) - Levi & Korsinsky, LLP notifies investors in Homology Medicines, Inc. ("Homology" or the "Company") (NASDAQ: FIXX) of a class action securities lawsu...

FINAL DEADLINE - Bronstein, Gewirtz & Grossman, LLC Reminds Homology Medicines, Inc. (FIXX) Shareholders of Class Act...

New York, New York--(Newsfile Corp. - May 24, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Homology Medicines, Inc. ("Homology" or the...

FIXX DEADLINE TODAY: ROSEN, A TOP RANKED FIRM, Encourages Homology Medicines, Inc. Investors With Losses to Secure Co...

New York, New York--(Newsfile Corp. - May 24, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June...

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Conta...

Los Angeles, California--(Newsfile Corp. - May 24, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Homology Medicines, Inc...

FIXX ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 24, 2022 in the Class Action Filed on Behal...

NEW YORK , May 24, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Homology Medicines, Inc. (NASDAQ: FIXX) alleging that the C...

FIXX LAWSUIT FILED: Jakubowitz Law Pursues Claims on Behalf of HOMOLOGY MEDICINES, INC. Shareholders

New York, New York--(Newsfile Corp. - May 23, 2022) - Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Homology Medicines, Inc. (NASDAQ: F...

FIXX FINAL DEADLINE: Hagens Berman, National Trial Attorneys, Encourages Homology Medicines (FIXX) Investors with Sig...

San Francisco, California--(Newsfile Corp. - May 23, 2022) - Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors who suffered significant losses to submit your losses now. A securities...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Homology Medicines, Inc. of a Class Action Lawsuit and...

New York, New York--(Newsfile Corp. - May 23, 2022) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of Homology Medicines, Inc. (NASDAQ: ...

FIXX DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Homology Medicines, Inc. Investors with Losses to...

NEW YORK , May 23, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June 10, 2019 and ...

FIXX LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Homology Medicines...

New York, New York--(Newsfile Corp. - May 23, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Homology Medicines, I...

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000 to Co...

Los Angeles, California--(Newsfile Corp. - May 23, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Homology Medicines, Inc...

INVESTOR DEADLINE TOMORROW: Investors in Homology Medicines, Inc. with Substantial Losses Have Opportunity to Lead Cl...

San Diego, California--(Newsfile Corp. - May 23, 2022) - Robbins Geller Rudman & Dowd LLP announces that purchasers of Homology Medicines, Inc. (NASDAQ: FIXX) securities between June 10, 2019 and Februa...

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Homology Investors of a Lead Plaintiff Deadline of May 24,...

NEW YORK , May 23, 2022 /PRNewswire/ -- Attention Homology Medicines, Inc. ("Homology") (NASDAQ: FIXX) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on...

TUESDAY INVESTOR DEADLINE: Homology Medicines, Inc. Investors with Substantial Losses Have Opportunity to Lead Class ...

San Diego, California--(Newsfile Corp. - May 20, 2022) - Robbins Geller Rudman & Dowd LLP announces that purchasers of Homology Medicines, Inc. (NASDAQ: FIXX) securities between June 10, 2019 and Februa...

TUESDAY DEADLINE NOTICE: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,000...

Los Angeles, California--(Newsfile Corp. - May 20, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Homology Medicines, Inc...

FIXX SHAREHOLDER ALERT: Jakubowitz Law Reminds Homology Shareholders of a Lead Plaintiff Deadline of May 24, 2022

NEW YORK , May 20, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Homology Medicines, Inc. (NASDAQ: FIXX). To recei...

FIXX LAWSUIT ALERT: Levi & Korsinsky Notifies Homology Medicines, Inc. Investors of a Class Action Lawsuit and Upcomi...

NEW YORK , May 19, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Homology Medicines, Inc. ("Homology" or the "Company") (NASDAQ: FIXX) of a class action securities lawsuit. CLASS DEFI...

TUESDAY DEADLINE REMINDER: The Schall Law Firm Encourages Investors in Homology Medicines, Inc. with Losses of $100,0...

Los Angeles, California--(Newsfile Corp. - May 19, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Homology Medicines, Inc...

Homology Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before May 24, 2022 to Discuss Your ...

New York, New York--(Newsfile Corp. - May 18, 2022) - Levi & Korsinsky, LLP notifies investors in Homology Medicines, Inc. ("Homology" or the "Company") (NASDAQ: FIXX) of a class action securities lawsu...

ROSEN, Top Ranked Investor Counsel, Encourages Homology Medicines, Inc. Investors with Losses to Secure Counsel Befor...

New York, New York--(Newsfile Corp. - May 18, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Homology Medicines, Inc. (NASDAQ: FIXX) between June...

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Homology Medicines (FIXX) Investors with Significant Losses to Co...

San Francisco, California--(Newsfile Corp. - May 18, 2022) - Hagens Berman urges Homology Medicines, Inc. (NASDAQ: FIXX) investors who suffered significant losses to submit your losses now. A securities...